SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,410 | -75.4% | 15,001 | -6.2% | 0.00% | – |
| Q2 2023 | $5,728 | +13.7% | 16,001 | +14.3% | 0.00% | – |
| Q1 2023 | $5,040 | +42.2% | 14,001 | +249.9% | 0.00% | – |
| Q4 2022 | $3,545 | -60.6% | 4,001 | -33.3% | 0.00% | – |
| Q3 2022 | $9,000 | -25.0% | 6,001 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -14.3% | 6,001 | 0.0% | 0.00% | – |
| Q1 2022 | $14,000 | -50.0% | 6,001 | 0.0% | 0.00% | – |
| Q4 2021 | $28,000 | -26.3% | 6,001 | +20.0% | 0.00% | – |
| Q3 2021 | $38,000 | -20.8% | 5,001 | 0.0% | 0.00% | – |
| Q2 2021 | $48,000 | +17.1% | 5,001 | 0.0% | 0.00% | – |
| Q1 2021 | $41,000 | +20.6% | 5,001 | 0.0% | 0.00% | – |
| Q4 2020 | $34,000 | -39.3% | 5,001 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $56,000 | +330.8% | 5,001 | +149.9% | 0.00% | – |
| Q2 2020 | $13,000 | – | 2,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
| KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
| AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
| TRUST CO OF VERMONT | 204 | $19 | 0.00% |
| SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
| Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
| Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |